Evidence map›Paper›PMID 26870815›Full record

ArticleEBioMedicine2016

Amelioration of Metabolic Syndrome-Associated Cognitive Impairments in Mice via a Reduction in Dietary Fat Content or Infusion of Non-Diabetic Plasma.

Lance A Johnson, Kristen L Zuloaga, Tara L Kugelman, Kevin S Mader, Jeff T Morré, Damian G Zuloaga, Sydney Weber, Tessa Marzulla, Amelia Mulford, Dana Button and 4 more

Open access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Sex Differences in Cognition Across Aging.Current topics in behavioral neurosciences · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Lance A JohnsonDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Kristen L ZuloagaDepartment of Anesthesiology and Perioperative Medicine, Oregon Health & Science University, Portland, OR 97239, USA.
Tara L KugelmanDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Kevin S MaderSwiss Federal Institute of Technology, Zurich, Switzerland; 4Quant, Paul Scherrer Institute, Villigen, Switzerland.
Jeff T MorréDepartment of Pharmaceutical Sciences, and the Linus Pauling Institute, Oregon State University, Corvallis, OR 97331, USA.
Damian G ZuloagaDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Sydney WeberDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Tessa MarzullaDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Amelia MulfordDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Dana ButtonDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Jonathan R LindnerKnight Cardiovascular Institute, Oregon Health & Science University, Portland, OR 97239, USA.
Nabil J AlkayedDepartment of Anesthesiology and Perioperative Medicine, Oregon Health & Science University, Portland, OR 97239, USA; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR 97239, USA.
Jan F StevensDepartment of Pharmaceutical Sciences, and the Linus Pauling Institute, Oregon State University, Corvallis, OR 97331, USA.
Jacob RaberDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA; Departments of Neurology and Radiation Medicine, Division of Neuroscience, ONPRC. Electronic address: raberj@ohsu.edu.
Oregon Health & Science University · USOregon State University · USPaul Scherrer Institute · CH

Funding

Reducing Susceptibility to Environmental Stress Throughout the Life SpanP30ES000210 · NIEHS · OREGON STATE UNIVERSITY · PI BECKMAN, JOSEPH S · 1985 to 2015
$21.4M
MODE OF ACTION OF ENVIRONMENTAL TOXICANTST32ES007060 · NIEHS · OREGON STATE UNIVERSITY · PI Jamie DeWitt, Siva Kumar Kolluri · 1985 to 2026
$11.6M
BIOLOGICAL BASES OF DRUG-SEEKING BEHAVIORT32DA007262 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAMS, JOHN T · 1991 to 2022
$9.4M
Training in Translational Science and Cardiovascular MedicineT32HL094294 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALKAYED, NABIL J · 2009 to 2018
$3.5M
Triple Quadrupole/Linear Ion Trap LC-MS/MS for LPIS10RR027878 · NCRR · OREGON STATE UNIVERSITY · PI STEVENS, JAN FREDERIK · 2010 to 2010
$484k
Endothelial Mechanism of Vascular Cognitive Impariment (VCI)R21AG043857 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALKAYED, NABIL J · 2013 to 2014
$424k
Endothelial Aromatase in Sex-Specific Cerebrovascular Dysfunction After IschemiaF32NS082017 · NINDS · REGENERATIVE RESEARCH FOUNDATION · PI ZULOAGA, KRISTEN LEANNE · 2012 to 2015
$159k
NCRR NIH HHS S10 RR027878NCRR NIH HHS S10RR027878NHLBI NIH HHS T32 HL094294NHLBI NIH HHS T32-HL094294NIA NIH HHS NIH R21AG043857NIA NIH HHS R21 AG043857NIDA NIH HHS T32 DA007262NIEHS NIH HHS P30 ES000210NIEHS NIH HHS P30ES000210NIEHS NIH HHS T32 ES007060NIEHS NIH HHS T32-ES07060NINDS NIH HHS F32 NS082017NINDS NIH HHS NIH F32NS082017PHS HHS NIDA T32DA007262
6 · The paper itself

Abstract

Obesity, metabolic syndrome (MetS) and type 2 diabetes (T2D) are associated with decreased cognitive function. While weight loss and T2D remission result in improvements in metabolism and vascular function, it is less clear if these benefits extend to cognitive performance. Here, we highlight the malleable nature of MetS-associated cognitive dysfunction using a mouse model of high fat diet (HFD)-induced MetS. While learning and memory was generally unaffected in mice with type 1 diabetes (T1D), multiple cognitive impairments were associated with MetS, including deficits in novel object recognition, cued fear memory, and spatial learning and memory. However, a brief reduction in dietary fat content in chronic HFD-fed mice led to a complete rescue of cognitive function. Cerebral blood volume (CBV), a measure of vascular perfusion, was decreased during MetS, was associated with long term memory, and recovered following the intervention. Finally, repeated infusion of plasma collected from age-matched, low fat diet-fed mice improved memory in HFD mice, and was associated with a distinct metabolic profile. Thus, the cognitive dysfunction accompanying MetS appears to be amenable to treatment, related to cerebrovascular function, and mitigated by systemic factors.

Indexed as

AnimalsBehavior, AnimalCerebrovascular CirculationCluster AnalysisCognition DisordersDietary FatsDiet, High-FatDisease Models, AnimalFemaleMaze LearningMetabolic SyndromeMetabolomeMetabolomicsMiceObesityRecognition, PsychologyDietary FatsADMA, Asymmetric dimethylarginineBDNF, Brain-derived neurotrophic factorBrainBr Fat, Brown adipose tissueBW, Body weightCBV, Cerebral blood volumeCerebrovascularCH, CholesterolCognitiveCxcl1, Ligand 1C-X-C motif, ChemokineDG, DiacylglycerolDiabetesFFA, Free fatty acidsGlcCer, GlucosylceramideGL, GlycerolipidGLP-1, Glucagon-like peptide 1GPL, GlycerophospholipidHFD, High fat dietIFNγ, Interferon-γIL-10, Interleukin-10IL-12p70, Interleukin-12p70Il-1b, Interleukin-1βIL-6, Interleukin-6IR, Insulin resistanceITT, Insulin tolerance testKB, Total ketone bodiesLFD, Low fat dietLPA, Lysophosphatidic acidMetabolic syndromeMetS, Metabolic syndromeObesityOGTT, Oral glucose tolerance testPC, PhosphatidylcholinePE, PhosphatidylethanolaminePG, PhosphatidylglycerolPGP, PhosphatidylglycerolphosphatePI, PhosphatidylinositolPlasmaPS, PhosphatidylserineSC Fat, Subcutaneous adipose tissueT1D, Type 1 DiabetesT2D, Type 2 DiabetesTG, TriglyceridesTNFα, Tumor necrosis factor-αV Fat, Visceral adipose tissue

Identifiers

PMID26870815
PMCPMC4739422
OpenAlexW2199659062

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.